Clinical Trial Update: Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aliskiren (a renin inhibitor) versus enalapril in C3 glomerulopathy and related glomerulonephritis, currently recruiting in Region Skan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulonephritis
• C3 Glomerulopathy
• Dense Deposit Disease
• Membranoproliferative Glomerulonephritis

Drugs mentioned

• Aliskiren (Aliskiren)
• Enalapril (enalapril)

Snippet

Sponsor: Region Skane | Conditions: C3 Glomerulopathy, Membranoproliferative Glomerulonephritis | Phase 2 | Status: RECRUITING